Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-04
T
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Tong Mu's research investigates the therapeutic potential of SB290157, a selective complement C3a receptor antagonist. This compound has demonstrated efficacy in ameliorating aortic dissection by suppressing inflammatory signaling pathways. The work aims to reduce inflammation and structural damage within the aortic wall, contributing to the understanding of cardiovascular disease mechanisms and potential pharmacological interventions.
Metrics
- Publications: 1
Selected Publications
-
SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage (2026)
Collaboration Network
Top Collaborators
Yutao Huang
Yangzhou University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Hongyan Ji
Ningxia Medical University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Hongliang Li
Yangzhou University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Xin Lu
Yangzhou University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Qi Liu
Yangzhou University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Junyi Yang
Yangzhou University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Xudong Liu
Ningxia Medical University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Jing Chen
Yangzhou University (CN)
1 shared publication
- SB290157, a selective complement C3a receptor antagonist, ameliorates aortic dissection by suppressing inflammatory signaling pathways to attenuate aortic wall inflammation and structural damage
Similar Researchers
Based on overlapping research topics
Mehta Jl
University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling
Cardiovascular Function and Risk Factors
Pharmacological Effects and Toxicity Studies
Andrew Morris
University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling
Immune Response and Inflammation
Cardiovascular Function and Risk Factors
Prathyusha Bagam
National Center for Toxicological Research
Receptor Mechanisms and Signaling
Immune Response and Inflammation
Cardiovascular Function and Risk Factors
Ji Li
University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling
Immune Response and Inflammation
Cardiovascular Function and Risk Factors
Ashim K. Bagchi
University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling
Immune Response and Inflammation
Cardiovascular Function and Risk Factors
Lisa N. Tyler
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research